We are live on ! Find out more
BLX icon

Bladex Inc

14 hedge funds and large institutions have $46.3M invested in Bladex Inc in 2021 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 6

0.32% less ownership

Funds ownership: 10.18%9.86% (-0.32%)

8% less capital invested

Capital invested by funds: $50.1M → $46.3M (-$3.77M)

13% less funds holding

Funds holding: 1614 (-2)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
14
Holders Change
-2
Holders Change %
-12.5%
% of All Funds
0.25%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
Increased
6
Reduced
6
Closed
2
Calls
Puts
Net Calls
Net Calls Change

BLX Hedge Fund Activity: Q1 2021 in Review

14 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Bladex Inc (BLX) for Q1 2021, worth a combined $46.3M — down 7.5% from $50.1M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of BLX and 0 opened new positions — a net loss of 2 holders — while 6 trimmed existing stakes and 6 added.

The largest buyer was Panagora Asset Management, adding an estimated $614K. The largest seller was LSV Asset Management, cutting an estimated $1.82M.

  • 14 institutional investors held Bladex Inc (BLX) as of Q1 2021, down from 16 in Q4 2020.
  • Funds reported $46.3M of Bladex Inc stock for Q1 2021, down 7.5% quarter-over-quarter.
  • 0 funds opened new Bladex Inc positions in Q1 2021 and 2 closed out, a net change of -2 holders.
  • The largest Bladex Inc buyer in Q1 2021 was Panagora Asset Management, an estimated $614K added.
  • The largest Bladex Inc seller in Q1 2021 was LSV Asset Management, an estimated $1.82M sold.

Based on aggregated 13F filings for Q1 2021.